2fjf: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2fjf" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fjf, resolution 2.65Å" /> '''Structure of the G6...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2fjf.gif|left|200px]]<br />
[[Image:2fjf.gif|left|200px]]<br /><applet load="2fjf" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2fjf" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2fjf, resolution 2.65&Aring;" />
caption="2fjf, resolution 2.65&Aring;" />
'''Structure of the G6 Fab, a phage derived VEGF binding Fab'''<br />
'''Structure of the G6 Fab, a phage derived VEGF binding Fab'''<br />


==Overview==
==Overview==
In the quest to discover new research tools and to develop better agents, in the fight against cancer, two antibodies, G6 and B20-4, were isolated, from synthetic antibody phage libraries. Unlike the AVASTINtrade mark, antibody, a recently approved agent for the treatment of patients with, colorectal cancer, B20-4 and G6 bind and block both human and murine, vascular endothelial growth factor (VEGF). Here we have analyzed and, compared the binding epitopes on VEGF for these three antibodies using, alanine-scanning mutagenesis and structural analyses. The epitopes, recognized by both synthetic antibodies are conserved between human and, mouse VEGF, and they match closely to the receptor epitopes both, structurally and functionally. In contrast, the Avastin epitope overlaps, minimally with the receptor binding surface and centers around a residue, that is not conserved in mouse. Our structural and functional analyses, elucidate the cross-species reactivity of all three antibodies and, emphasize the potential advantages of antibody generation using phage, display as the resulting antibodies do not depend on sequence differences, across species and preferentially target natural protein-protein, interaction surfaces.
In the quest to discover new research tools and to develop better agents in the fight against cancer, two antibodies, G6 and B20-4, were isolated from synthetic antibody phage libraries. Unlike the AVASTINtrade mark antibody, a recently approved agent for the treatment of patients with colorectal cancer, B20-4 and G6 bind and block both human and murine vascular endothelial growth factor (VEGF). Here we have analyzed and compared the binding epitopes on VEGF for these three antibodies using alanine-scanning mutagenesis and structural analyses. The epitopes recognized by both synthetic antibodies are conserved between human and mouse VEGF, and they match closely to the receptor epitopes both structurally and functionally. In contrast, the Avastin epitope overlaps minimally with the receptor binding surface and centers around a residue that is not conserved in mouse. Our structural and functional analyses elucidate the cross-species reactivity of all three antibodies and emphasize the potential advantages of antibody generation using phage display as the resulting antibodies do not depend on sequence differences across species and preferentially target natural protein-protein interaction surfaces.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2FJF is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FJF OCA].  
2FJF is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FJF OCA].  


==Reference==
==Reference==
Line 22: Line 21:
[[Category: fab]]
[[Category: fab]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:06:13 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:22:02 2008''